A study conducted on patients with type 2 diabetes shows that semaglutide significantly lowers their risk of complications.

Published Date: 29 May 2024

In patients with type 2 diabetes and chronic kidney disease, semaglutide significantly lowers the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality, according to a ground-breaking study.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Examines Office-Based Transperineal Prostate Biopsies Methodology.

2.

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

3.

Is a $2,000 Whole-Body MRI Worth It?

4.

Surgery may not be necessary to treat invasive breast cancer

5.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot